Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Merck Patent Gesellschaft Patents
Assignee:
Merck Patent Gesellschaft
Address:
Darmstadt, DE
No. of patents:
105
Patents:


1 2 3










Patent Number Title Of Patent Date Issued
RE37270 Liquid crystal phase July 10, 2001
Liquid crystal phases containing components of the formulae I and III ##STR1##have an acceptable combination of threshold steepness, viewing angle and temperature dependence at a low threshold voltage.
8236804 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine August 7, 2012
The invention relates to new crystalline modifications of the hydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine- , crystalline modification of the dihydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine
8193195 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hy June 5, 2012
The invention relates to new crystalline modifications of the hydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine- , crystalline modification of the dihydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine
7981894 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hyd July 19, 2011
The invention relates to new crystalline modifications of the hydrochloride of 1-[4-(5-cyanoindol-3-yl) butyl]-4-(2-carbomyl-benzofuran-5-yl)-piperazine, crystaline modification of the dihydrochloride of 1-[4-(5-cyanoindol-3-yl) butyl]-4-(2-carbomyl-benzofuran-5-yl)-piperazine and am
7955664 Chroman compounds June 7, 2011
The chroman compounds of the formula I according to the invention R.sup.1-(A.sup.1-Z.sup.1).sub.a--W.sup.1--(Z.sup.2-A.sup.2).sub.b-Z.sup.3- --W.sup.2--(Z.sup.4-A.sup.3).sub.c-R.sup.2 in which R.sup.1, A.sup.1, A.sup.2, A.sup.3, W.sup.1, W.sup.2, Z.sup.1, Z.sup.2, Z.sup.3, Z.sup.4, a
7888519 Pyran compound or at least one derivative thereof February 15, 2011
The invention relates to pyran derivatives of the formula I ##STR00001## and to a process and intermediates for their preparation and derivatisation, and to the use thereof in liquid-crystalline media.
7872039 3-aminoindazoles January 18, 2011
Novel 3-aminoindazoles of the formula (I) are SGK inhibitors and can be used for the treatment of SGK-induced diseases and conditions, such as diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and renal diseases, general
7858376 Ninhydrin and ionic liquid reagent mixture and method for the visualization of amino acids and p December 28, 2010
The invention relates to a method and reagent mixture for the staining and thus visualization of amino acids, peptides and similar compounds, in particular after separation by means of thin-layer chromatography. The staining is carried out using ninhydrin for the detection of amino acids
7834020 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine November 16, 2010
The invention relates to new crystalline modifications of the hydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine- , crystalline modification of the dihydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine
7829658 Mono-, oligo- and polymers of thienothiazole November 9, 2010
The invention relates to novel mono-, oligo- and polymeric compounds comprising thienothiazole groups, to their use as semiconductors or charge transport materials, in optical, electro-optical or electronic devices, and to optical, electro-optical or electronic devices comprising the
7807236 Liquid-crystalline medium October 5, 2010
The invention relates to a liquid-crystalline medium, characterised in that it comprises one or more compounds of the formula I ##STR00001## in which R.sup.0, L.sup.1, n, A and B have the meanings indicated in Claim 1, furthermore to novel compounds of the formula I, to processes for th
7807068 Polymerizable compounds October 5, 2010
The present invention relates to novel polymerizable compounds, to processes and intermediates for the preparation thereof, and to the use thereof for optical, electro-optical and electronic purposes, in particular in liquid-crystal (LC) media and LC displays, especially in LC displa
7691456 Spiro[3.3] heptyl-dioxan derivatives and their use in liquid crystal media April 6, 2010
The invention relates to novel dioxane derivatives of the formula R.sup.1-(A.sup.1-Z.sup.1).sub.m-G-(Z.sup.2-A.sup.2).sub.n-R.sup.2, in which G denotes (I) or (II), and in which R.sup.1, R.sup.2, A.sup.1, A.sup.2, Z.sup.1, Z.sup.2, m and n have the meanings indicated in claim 1, to t
7658978 Liquid crystalline medium February 9, 2010
The invention relates to a liquid crystalline medium containing one or more compounds of formula I, wherein R.sup.1 and R.sup.2 have the meanings described in claim 1, to its use for electrooptical purposes, and to displays containing this medium. ##STR00001##
7656490 LC display device with parallel field component February 2, 2010
An electro-optical display device comprising a liquid crystal layer achieves switching using an electric field component which is predominantly parallel to the surface of the liquid crystal layer. Low dependence of image contrast on viewing angle is achieved by selection of parameter
7648646 LC material with homeotropic alignment January 19, 2010
The invention relates to a liquid crystal (LC) material that aligns homeotropically on substrates with high or low surface energy.
7629257 Combined etching and doping substances December 8, 2009
The invention concerns etching and doping substances free of hydrochloric/fluoride acid used for etching inorganic layers as well as for doping subjacent layers. The invention also concerns a method wherein said substances are used.
7618988 Use of substituted aminomethyl chromans November 17, 2009
Compounds of formula I in which R has a meaning as indicated in claim 1, or one of their optical isomers or pharmaceutically acceptable salts, used for the treatment of extrapyramidal movement disorders and/or adverse effects in extrapyramidal movement disorders and/or for the treatm
7582656 Guanidine derivatives and therapeutic uses thereof September 1, 2009
Compounds of the formula (I): ##STR00001## in which the radicals R and R.sup.1 to R.sup.10 are as defined in the description,processes for the preparation of them,use thereof for the treatment of cardiovascular diseases, andpharmaceutical compositions comprising them.
7534785 3,6-dihydro-2-oxo-6H-1,3,4,-thiadiazine derivatives May 19, 2009
Compounds of the formula I, in which R1, R2, Q and B have the meanings indicated in claim 1, are inhibitors of tyrosine kinases, in particular Met kinase, and can be employed, inter alia, for the treatment of tumours. ##STR00001##
7329749 Piperazinylcarbonylquinolines and -isoquinolines February 12, 2008
Compound of the formula (I) in which R.sup.1, R.sup.2 and alk are as defined in Claim 1, are potent 5-HT.sub.2A antagonist and are suitable for the treatment of psychoses, schizophrenia, depression, neurological disorders, memory disorders, Parkinson's disease, amyotrophic lateral sc
7285681 Biguanide derivatives October 23, 2007
The present invention relates to biguanide derivatives of formula (I), wherein R1, R2, R3 and R4 have the meanings as given in claim (1). Compounds are useful in the treatment of pathologies associated with hyperglycaemia, such as diabetes. ##STR00001##
7271302 Method for brominating organic compounds September 18, 2007
The present invention relates to processes for the bromination of organic compounds, and to bromination microreactors for carrying out these processes.
7264795 Sunscreen composition September 4, 2007
The present invention relates to a composition having UV protection properties, charaterized in that the formulation comprises at least one encapsulated organic sunscreen and does not penetrate the skin essentially.
7264670 Coloured microstructured effect pigments September 4, 2007
Disclosed are colored flake-form effect pigments comprising one or more layers, where at least one of the layers comprises one or more colorants or is itself a colorant and at least one of the layers has a groove or grid structure, and to processes for the preparation thereof, and to the
7262216 Benzofuran compounds and their use as antidepressants and anxiolytics August 28, 2007
Novel benzofuran derivatives of the formula (I) in which R.sup.1, R.sup.2, X, Y, Z and m have the meanings indicated in Patent Claim 1, they have a strong affinity to the 5-HT.sub.1A receptors. The compounds inhibit serotonin reuptake, exhibit serotonin-agonistic and -antagonistic pr
7241502 Moulded bodies consisting of core-shell particles July 10, 2007
The invention relates to mouldings having an optical effect which essentially consist of core/shell particles whose shell forms a matrix and whose core is essentially solid and has an essentially monodisperse size distribution, where a difference exists between the refractive indices
7238757 Oxygen-containing organoaluminium complexes as cocatalysts July 3, 2007
Disclosed are compounds of formula (I) ##STR00001## which compounds are useful as cocatalysts in olefinic polymerisation reactions, e.g., as Ziegler-Natta catalysts.
7220464 Nematic liquid-crystal mixture, and displays containing same May 22, 2007
A nematic liquid-crystal mixture contains a compound of formula I ##STR00001## in which R.sup.11 and R.sup.12 are as defined in the specification, and a liquid-crystal displays containing same.
7208626 Method for the production of perfluoroalkyl phosphines and the use thereof as perfluoroalkylatin April 24, 2007
The invention relates to a method for producing perfluoroalkyl phosphines, comprising at least one step in which at least one fluoro(perfluoroalkyl)phosphorane is reacted with at least one hydride ion donator, and the use of tris(perfluoroalkyl)phos-phines as perfluoroalkylating reac
7199133 Derivatives of phenoxy-n-'4-(isothiazolindin-1, 1-dioxid-2yl)phenyll-valerian-acid amide and oth April 3, 2007
Novel compounds of formula (I), wherein D, W, X, Y, T and R.sup.1 have the meanings cited in claim 1, are inhibitors of coagulation factor Xa and can be used for the prophylaxis and/or therapy of thromboembolic diseases and in the treatment of tumors ##STR00001##
7198828 Liquid-crystalline medium April 3, 2007
The invention relates to a liquid-crystalline medium which is characterized in that it comprises one or more compounds of the formula A ##STR00001## and at least one compound of the formula B ##STR00002## in which R.sup.a, R.sup.b, Y, Z.sup.1, Z.sup.2, L.sup.1, L.sup.2, L.sup.3, L.
7186358 Polymer dopants March 6, 2007
A polymer dopant for electrially conducting, photoconducting and semiconducting components and devices and novel polymers comprising electron accepting groups that are suitable as polymer dopants.
7183418 Mono-, oligo- and polythieno[2,3-b]thiophenes February 27, 2007
The invention relates to novel mono-, oligo and poly[2,3-b]-thienothiophenes, their use as semiconductors or charge transport materials, in optical, electro-optical or electronic devices like for example liquid crystal displays, optical films, organic field effect transistors (FET or
7166720 Process for the preparation of .alpha.-aminosubstituted carboxylic acid amides January 23, 2007
Hydroxy-imino derivatives of formula IIb are disclosed, ##STR00001## in which R and R.sup.1 have the meanings given in the description.
7153550 Liquid crystalline medium and liquid crystal display December 26, 2006
The instant invention relates to liquid crystalline media comprising a dielectrically positive component, component A, consisting of dielectrically positive compounds, comprising one or more compounds of formula I and one or more compounds of formula II ##STR00001## wherein the para
7145004 Method for the production of monohydro-perfluoroalkanes, bis(perfluoroalkyl)phosphinates and per December 5, 2006
The present invention relates to a process for the preparation of monohydroperfluoroalkanes, bis(perfluoroalkyl)phosphinates and perfluoroalkylphosphonates which comprises at least the treatment of at least one perfluoroalkylphosphorane with at least one base in a suitable reaction m
7141572 Hydrazono-malonitriles November 28, 2006
Hydrazono-malonitrile derivatives of the formula (I) in which R.sup.1, R.sup.2, R.sup.3, R.sup.3' and R.sup.4 have the meanings given in Claim 1 act as phosphodiesterase IV inhibitors and can be employed for the treatment of osteoporosis, tumours, cachexia, atherosclerosis, rheumatoid
7129241 Pyridazine derivatives October 31, 2006
Pyridazine derivatives of the formula (I) act as phosphodiesterase IV inhibitors and can be employed for the treatment of osteoporosis, tumours, cachexia, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, inflammatory processes, allergies, asthma, autoimmu
7122227 Chiral photoisomerizable compounds October 17, 2006
The invention relates to chiral photoisomerizable compounds of formula (I) wherein X.sup.1, X.sup.2, X.sup.3, X.sup.4, X.sup.5 and X.sup.6 have the meanings given in claim 1, to liquid crystalline mixtures and polymers containing them, and to the use of chiral photoisomerizable compounds
7105708 Method for producing compounds having a CF.sub.2O bridge September 12, 2006
The invention relates to a process for the preparation of compounds containing at least one --CF.sub.2--O-- bridge in the molecule, in which a) an acid is added onto at least one ketene dithioketal, b) the resultant bis(alkylthio)carbenium salt is reacted with at least one compound h
7101537 Tricyclic quinoxaline and quinoline derivatives as a UV filter September 5, 2006
The invention relates to the use of quinoxaline derivatives of formula I, represented by formulas 1a and 1b, as photostable UV filters, in particular in cosmetic and pharmaceutical preparations for protecting the human epidermis or human hair against UV radiation, above all in the 280
7060774 Prepolymer material, polymer material, imprinting process and their use June 13, 2006
The invention relates to a prepolymer material based on monomeric, oligomeric or polymeric compounds with at least one ethylenically unsaturated (meth)acryloyl group. The problem of imperfect imprinting properties, escpecially of an unwanted adhering to the imprinting stamp or mold,
6998254 Use of ROR for receptors for screening substances useful for the treatment of atherosclerosis February 14, 2006
The subject of the present invention is the use of the ROR receptors and/or of their response element or alternatively of a functional equivalent thereof for the screening of substances having antiatherosclerotic properties. The invention also relates to the methods of screening subs
6995241 Splice variant of head trauma induced cytoplasmatic calcium binding protein February 7, 2006
ANIC-BP-1B polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing ANIC-BP-1B polypeptides and polynucleotides in diagnostic assays.
6812015 Histidine protein-phosphatase November 2, 2004
The invention relates to a novel enzyme, histidine protein phosphatase, which is derived from mammalian sources, and its homologue variants. The invention further relates to DNA sequences encoding said proteins, to a process for preparing the latter, and to antibodies directed against th
6800338 Electro-optical liquid-crystal display October 5, 2004
To provide an electro-optical liquid-crystal displays with low addressing voltages and low to moderate multiplex ratios, in particular STN displays, organic alignment layers of low layer thickness are utilized.
6730314 Culturing encapsulated chondrocytes under reduced oxygen partial pressure to produce cartilage i May 4, 2004
A process is provided for the production of a human cartilage implant from chondrocytes cultured in vitro, which come as close as possible to the original with respect to their biochemical composition and biomechanical properties. Up to 20% vol. of human serum is used as medium addition
6726856 Process for preparing electrically conductive pigments April 27, 2004
The invention relates to a process for preparing electrically conductive pigments based on F.sup.- - and/or PO.sub.4.sup.3- -doped tin mixed oxides applied as an electrically conductive layer to a substrate, in which, first of all, SnO.sub.2 -coated substrates are prepared by precipitati
6689205 Multilayer interference pigments February 10, 2004
Multilayer interference pigment consisting of a transparent carrier material coated with alternating layers of metal oxides of low and high refractive index, the difference in the refractive indices being at least 0.1, which is obtainable by alternate coating of the transparent carrier
1 2 3

 
 
  Recently Added Patents
Lens driving device
Power consumption management in a MIMO transceiver and method for use therewith
Process for producing dipeptides or dipeptide derivatives
Managing multiple web services on a single device
5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases
Method and apparatus for radio antenna frequency tuning
Display for gloves
  Randomly Featured Patents
Faucet
Method for de novo detection of sequences in nucleic acids: target sequencing by fragmentation
Snagproof helmut camouflage cover
Combuster for gas turbine system having a heat exchanging structure catalyst
Reduction of aberrations produced by Wien filter in a scanning electron microscope and the like
Resilient high shrinkage propylene polymer yarn and articles made therefrom
Surfacially cross-linked elastoplastic articles, and method of making the same
Method for producing highly purified, tris-and bis-ortho-metallated organometallic compounds
Wristband
Measuring quantum states of superconducting resonators